Company Profile
Dare Bioscience, Inc. Stock Price, News & Analysis
- Ticker:
- DARE
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.33 USD (-0.75%)
Close
Last updated: August 6, 2026
32.1M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, DARE closed down 0.75% at $1.33. No new same-company headline was identified in the current news window.
Company overview
Business overview
Dare Bioscience is a women’s health biotechnology company focused on contraceptive and reproductive-health innovation. Its story centers on developing products that address gaps in women’s health and family planning.
Geographic Base and Sector Classification
Dare is headquartered in the United States and listed on NASDAQ. It sits in specialty women’s health biotechnology.
Business Model Characteristics
The company depends on clinical progress, commercial strategy, and the ability to keep a focused women’s-health pipeline funded. Investors watch product development and market access.
Position Within the Biotechnology Landscape
Dare occupies a niche women’s-health position within biotech. It is more focused on reproductive-health innovation than on broad therapeutic diversification.
Future catalysts
Daré’s catalysts are hormonal-contraception and women’s-health programs, plus any commercial step that clarifies the company’s path. The market will care about execution more than concept.
Recent news
- 01
Daré Bioscience Regains Compliance with Nasdaq Minimum Equity Rule and Secures Capital to Advance Product Candidates
Source: Dare Bioscience, Inc.
- 02
Daré Bioscience to Present at the 2020 BIO CEO & Investor Conference
Source: Dare Bioscience, Inc.
- 03
Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule
Source: Dare Bioscience, Inc.
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Dare Bioscience, Inc. (DARE)?
Dare Bioscience, Inc. (DARE) most recently closed at 1.33 USD, a -0.75% move versus the previous session.
What is the market cap of Dare Bioscience, Inc. (DARE)?
Dare Bioscience, Inc. currently has a market capitalization of 32.1M USD on BioPharmSignal.
What does Dare Bioscience, Inc. do?
Dare Bioscience is a women’s health biotechnology company focused on contraceptive and reproductive-health innovation. Its story centers on developing products that address gaps in women’s health and family planning.
On which exchange is DARE stock listed?
Dare Bioscience, Inc. (DARE) is associated with NASDAQ, United States, Biopharma.
What is Dare?
Dare Bioscience is a women’s health biotechnology company focused on contraceptive and reproductive-health innovation.
Which conditions is Dare Bioscience, Inc. targeting with Dare?
Dare Bioscience is a women’s health biotechnology company focused on contraceptive and reproductive-health innovation. Its story centers on developing products that address gaps in women’s health and family planning. Daré’s catalysts are hormonal-contraception and women’s-health programs, plus any commercial step that clarifies the company’s path. The...
How does Dare Bioscience, Inc. describe recent progress with Dare?
Daré’s catalysts are hormonal-contraception and women’s-health programs, plus any commercial step that clarifies the company’s path. The market will care about execution more than concept.
What is Bioscience?
Dare Bioscience is a women’s health biotechnology company focused on contraceptive and reproductive-health innovation.